FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2226752915> ?p ?o ?g. }

• W2226752915 abstract "Treatments to reduce the amyloid plaque burden in the aging, cognitively normal population may prevent or delay the development of dementia. Pittsburgh compound B (PiB) binds to amyloid plaque and provides a surrogate for amyloid β pathology using PET. PiB-PET retention is a frequent finding in the aging, cognitively normal population. We investigated whether the treatment of postmenopausal women with menopausal hormone therapy (MHT) would have an association with amyloid burden measured by PiB-PET. Participants were recruited from the Kronos Early Estrogen Prevention Study (KEEPS), which was a randomized, placebo controlled trial to evaluate cardiovascular effects of MHT in recently menopausal women. PiB imaging was performed on a subgroup of subjects about 7 years after initiating 4 years of MHT where women within 6-36 months of their last menses had been randomized to either oral conjugated equine estrogen (CEE), Premarin, 0.45mg/day (N=17); or transdermal 17β-estradiol (TE), Climara, 50μg/day (N=21) (each with progesterone 200mg/day for 12 days/month) or placebo pills and patch (N=30). Participants had full clinical and neuropsychometric assessments. PiB images from each group were compared after treatment using a global SUVr measurement as a continuous measure. Positive PiB-PET scans were seen in 3(18%), 1(5%) and 1(3%) with median(range) SUVr's of 1.27 (1.19, 1.76), 1.25 (1.12, 1.75), 1.28 (1.20, 1.44) in the CEE, TE, and placebo groups respectively. A trend for reduced PiB retention was seen in the TE group vs. placebo (p=0.08). Among women who were APOE 4+ (N=18), we observed differences in PiB retention between CEE vs. TE (p=0.049) and TE vs. placebo (p=0.055) groups. No significant differences were observed in APOE 4- participants (n=40). (Figure). Boxplots of PiB ratios by treatment status. For ε4 positive only (right box), the p-values between 3 groups are as follows; CEE vs. Estradiol = 0.049, CEE vs. Placebo = 0.25 and Estradiol vs. Placebo = 0.055. The box on left has all subjects with e4 positives in red. The middle box has e4 negative subjects only. P-values are from Kruskal-Wallis and Wilcoxon rank sum tests. PiB cutoff for positivity at 1.4 is shown by a red-hashed line. These preliminary findings in a small number of women suggest an active role of TE for reducing amyloid brain deposition in postmenopausal women when treated for 4 years, shortly after menopause. These data may provide the rationale for a clinical trial to further investigate these findings in a larger population. These findings would support the observation that 17β-estradiol reduces the release of Aβ peptides in preclinical models. This interaction seems to be most pronounced in APOE 4+ women." @default.
• W2226752915 created "2016-06-24" @default.
• W2226752915 creator A5001313680 @default.
• W2226752915 creator A5005099850 @default.
• W2226752915 creator A5013894575 @default.
• W2226752915 creator A5030579684 @default.
• W2226752915 creator A5030804900 @default.
• W2226752915 creator A5037957960 @default.
• W2226752915 creator A5040832215 @default.
• W2226752915 creator A5050718938 @default.
• W2226752915 creator A5057493616 @default.
• W2226752915 creator A5077933873 @default.
• W2226752915 creator A5082931849 @default.
• W2226752915 creator A5090710393 @default.
• W2226752915 date "2015-07-01" @default.
• W2226752915 modified "2023-10-08" @default.
• W2226752915 title "IC-P-033: Treatment with 17β-estradiol in postmenopausal women is associated with lower PiB-PET retention" @default.
• W2226752915 doi "https://doi.org/10.1016/j.jalz.2015.06.053" @default.
• W2226752915 hasPublicationYear "2015" @default.
• W2226752915 type Work @default.
• W2226752915 sameAs 2226752915 @default.
• W2226752915 citedByCount "0" @default.
• W2226752915 crossrefType "journal-article" @default.
• W2226752915 hasAuthorship W2226752915A5001313680 @default.
• W2226752915 hasAuthorship W2226752915A5005099850 @default.
• W2226752915 hasAuthorship W2226752915A5013894575 @default.
• W2226752915 hasAuthorship W2226752915A5030579684 @default.
• W2226752915 hasAuthorship W2226752915A5030804900 @default.
• W2226752915 hasAuthorship W2226752915A5037957960 @default.
• W2226752915 hasAuthorship W2226752915A5040832215 @default.
• W2226752915 hasAuthorship W2226752915A5050718938 @default.
• W2226752915 hasAuthorship W2226752915A5057493616 @default.
• W2226752915 hasAuthorship W2226752915A5077933873 @default.
• W2226752915 hasAuthorship W2226752915A5082931849 @default.
• W2226752915 hasAuthorship W2226752915A5090710393 @default.
• W2226752915 hasBestOaLocation W22267529151 @default.
• W2226752915 hasConcept C126322002 @default.
• W2226752915 hasConcept C126894567 @default.
• W2226752915 hasConcept C142724271 @default.
• W2226752915 hasConcept C204787440 @default.
• W2226752915 hasConcept C27081682 @default.
• W2226752915 hasConcept C2777164284 @default.
• W2226752915 hasConcept C2778562196 @default.
• W2226752915 hasConcept C2779134260 @default.
• W2226752915 hasConcept C2779483572 @default.
• W2226752915 hasConcept C2781073650 @default.
• W2226752915 hasConcept C2908647359 @default.
• W2226752915 hasConcept C29456083 @default.
• W2226752915 hasConcept C2989005 @default.
• W2226752915 hasConcept C71924100 @default.
• W2226752915 hasConcept C81603835 @default.
• W2226752915 hasConcept C98274493 @default.
• W2226752915 hasConcept C99454951 @default.
• W2226752915 hasConceptScore W2226752915C126322002 @default.
• W2226752915 hasConceptScore W2226752915C126894567 @default.
• W2226752915 hasConceptScore W2226752915C142724271 @default.
• W2226752915 hasConceptScore W2226752915C204787440 @default.
• W2226752915 hasConceptScore W2226752915C27081682 @default.
• W2226752915 hasConceptScore W2226752915C2777164284 @default.
• W2226752915 hasConceptScore W2226752915C2778562196 @default.
• W2226752915 hasConceptScore W2226752915C2779134260 @default.
• W2226752915 hasConceptScore W2226752915C2779483572 @default.
• W2226752915 hasConceptScore W2226752915C2781073650 @default.
• W2226752915 hasConceptScore W2226752915C2908647359 @default.
• W2226752915 hasConceptScore W2226752915C29456083 @default.
• W2226752915 hasConceptScore W2226752915C2989005 @default.
• W2226752915 hasConceptScore W2226752915C71924100 @default.
• W2226752915 hasConceptScore W2226752915C81603835 @default.
• W2226752915 hasConceptScore W2226752915C98274493 @default.
• W2226752915 hasConceptScore W2226752915C99454951 @default.
• W2226752915 hasIssue "7S_Part_1" @default.
• W2226752915 hasLocation W22267529151 @default.
• W2226752915 hasOpenAccess W2226752915 @default.
• W2226752915 hasPrimaryLocation W22267529151 @default.
• W2226752915 hasRelatedWork W1944289944 @default.
• W2226752915 hasRelatedWork W2016978785 @default.
• W2226752915 hasRelatedWork W2039123589 @default.
• W2226752915 hasRelatedWork W2061809986 @default.
• W2226752915 hasRelatedWork W2101458969 @default.
• W2226752915 hasRelatedWork W2333475095 @default.
• W2226752915 hasRelatedWork W3017193929 @default.
• W2226752915 hasRelatedWork W4233016836 @default.
• W2226752915 hasRelatedWork W4308498428 @default.
• W2226752915 hasRelatedWork W4310558230 @default.
• W2226752915 hasVolume "11" @default.
• W2226752915 isParatext "false" @default.
• W2226752915 isRetracted "false" @default.
• W2226752915 magId "2226752915" @default.
• W2226752915 workType "article" @default.